Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
  1. 4 Grant or award Director acquired 2,941 shares (grant or award)
  2. 4 Planned sale Chief Executive Officer sold 100,000 shares at $4.76 ($476,000)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 7,057 shares (to pay taxes)
  4. 4 Planned sale Chief Executive Officer sold 100,000 shares at $4.71 ($471,000)
  5. 4 Planned sale Chief Executive Officer sold 100,000 shares at $4.84 ($484,000)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 11,908 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Executive Officer gave up 40,390 shares (to pay taxes)
  8. 4 Open-market sale Chief R&D Commercial Officer sold 36,599 shares at $5.52 ($202,173)
  9. 4 Planned sale Chief Executive Officer sold 618,175 shares at $5.28 ($3,263,964)
  10. 4 Grant or award Director acquired 1,949 shares (grant or award)
  11. 4 Grant or award Director acquired 2,924 shares (grant or award)
  12. 4 Grant or award Director acquired 22,016 shares (grant or award)
  13. 4 Grant or award Director acquired 22,016 shares (grant or award)
  14. 4 Grant or award Director acquired 22,016 shares (grant or award)
  15. 4 Grant or award Director acquired 22,016 shares (grant or award)
  16. 4 Grant or award Director acquired 11,008 shares (grant or award)
  17. 4 Grant or award Director acquired 22,016 shares (grant or award)
  18. 4 Grant or award Director acquired 11,008 shares (grant or award)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 7,057 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief R&D Commercial Officer gave up 3,796 shares (to pay taxes)

Page 5 of 26 · 512 filings